
Can-Fite BioPharma Ltd. CANF
€ 3.63
1.68%
Geschäftsbericht 2024
hinzugefügt 17.01.2026
Can-Fite BioPharma Ltd. DSO 2011-2026 | CANF
DSO Jährlich Can-Fite BioPharma Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 28.1 | 46.9 | 1.37 K | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.37 K | 28.1 | 482 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Adagene
ADAG
|
53.8 | $ 2.19 | 7.88 % | $ 123 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.31 | 1.22 % | $ 7.96 B | ||
|
BioXcel Therapeutics
BTAI
|
16.3 | $ 1.83 | 0.83 % | $ 4.64 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.09 | -0.21 % | $ 1.26 B | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Coherus BioSciences
CHRS
|
263 | $ 2.03 | 27.67 % | $ 191 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 230.76 | 0.92 % | $ 5 B | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.72 | 0.37 % | $ 17.1 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
25.7 | $ 42.02 | 1.74 % | $ 4.34 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
44.2 | $ 24.23 | -0.9 % | $ 2.87 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 70.82 | 1.77 % | $ 9.47 B | ||
|
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Champions Oncology
CSBR
|
66.5 | $ 6.9 | -0.43 % | $ 94.3 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Biogen
BIIB
|
57.9 | $ 171.66 | -1.23 % | $ 25 B | ||
|
Baudax Bio
BXRX
|
126 | - | 0.59 % | $ 63 K |